Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Scientists reached this finding thanks to a highly precise means of sequencing HIV’s genetics.
The researchers studied a new compound that blocked a key viral protein that prompts infected cells to produce more virus.
Gilead Sciences’ second round of cure grants supports these five research projects.
This Ohio researcher will be using CRISPR gene editing to target HIV, thanks to funding from The Campbell Foundation.
Defective copies of HIV distract the immune system in order to promote overall infection.
Highlights from the research presented at the 9th International AIDS Society Conference on HIV Science in Paris.
He started HIV treatment immediately, and after sensitive tests showed near-complete loss of virus, he stopped after 34 months.
The 13 new grants support innovative approaches such as gene therapy.
However, the drug does not reduce the size of the reservoir.
The child was treated with antiretrovirals for only 40 weeks starting at 9 weeks of age and has since maintained a fully suppressed virus.
The social media buzz on this gene-editing technology [SLIDESHOW]
Carl W. Dieffenbach, PhD, of the National Institutes of Health reacts to the $1 million crowdfunding campaign launched by a Sia music video.
The Offspring’s singer-guitarist had put his molecular biology studies on hold for nearly 20 years.
Researchers have discovered how HIV manages to infect macrophage immune cells, which can be a key part of the viral reservoir.
The feat marks an important milestone in the mammoth effort to find a cure for HIV.
Researchers have found that in addition to CD4s, macrophage cells can harbor HIV even in the face of antiretroviral treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.